Is the use of sentient animals in basic research justifiable?

Philosophy, Ethics, and Humanities in Medicine

Volumn 5, Issue 1, 2010, Pages

  Greek, Ray ^a   Greek, Jean ^a  

^a Americans For Medical Advancement   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL EXPERIMENT; CONSCIOUSNESS; ETHICS; HUMAN; MEDICAL RESEARCH; METHODOLOGY; POLICY; RESEARCH ETHICS; REVIEW; UNITED STATES;

ANIMAL EXPERIMENTATION; ANIMALS; BIOMEDICAL RESEARCH; CONSCIOUSNESS; ETHICS, RESEARCH; HUMANS; PUBLIC POLICY; UNITED STATES;

EID: 77956481405     PISSN: None     EISSN: 17475341     Source Type: Journal    
DOI: 10.1186/1747-5341-5-14     Document Type: Review

References (133)

1. Shanks N, Greek R, Greek J. Are animal models predictive for humans?. Philos Ethics Humanit Med 2009, 4:2. 10.1186/1747-5341-4-2, 2642860, 19146696.
2. Shanks N, Greek R. Animal Models in Light of Evolution 2009, Boca Rotan: Brown Walker, (2b, see Appendix 3).
3. Calabrese EJ. Suitability of animal models for predictive toxicology: theoretical and practical considerations. Drug Metab Rev 1984, 15:505-523. 10.3109/03602538409029971, 6435984.
4. Calabrese EJ. Principles of Animal Extrapolation 1991, Boca Rotan: CRC Press.
5. Collins JM. Inter-species differences in drug properties. Chem Biol Interact 2001, 134:237-242. 10.1016/S0009-2797(01)00158-2, 11336972.
6. Fletcher AP. Drug safety tests and subsequent clinical experience. J R Soc Med 1978, 71:693-696. 1436259, 712750.
7. Garattini S. Toxic effects of chemicals: difficulties in extrapolating data from animals to man. Crit Rev Toxicol 1985, 16:1-29. 10.3109/10408448509041323, 3910353.
8. Hackam DG. Translating animal research into clinical benefit. BMJ 2007, 334:163-164. 10.1136/bmj.39104.362951.80, 1782020, 17255568.
9. Hackam DG, Redelmeier DA. Translation of research evidence from animals to humans. JAMA 2006, 296:1731-1732. 10.1001/jama.296.14.1731, 17032985.
10. Heywood R. Target organ toxicity II. Toxicol Lett 1983, 18:83-88. 10.1016/0378-4274(83)90075-9, 6623552.
11. Heywood R. Clinical Toxicity--Could it have been predicted? Post-marketing experience. Animal Toxicity Studies: Their Relevance for Man 1990, 57-67. Lancaster: Quay, Lumley CE, Walker S.
12. Igarashi T. The duration of toxicity studies required to support repeated dosing in clinical investigation--A toxicologists opinion. CMR Workshop: The Timing of Toxicological Studies to Support Clinical Trials 1994, 67-74. Boston: Kluwer, C Parkinson NM, Lumley C, Walker SR.
13. Igarashi T, Nakane S, Kitagawa T. Predictability of clinical adverse reactions of drugs by general pharmacology studies. J Toxicol Sci 1995, 20:77-92.
14. Igarashi T, Yabe T, Noda K. Study design and statistical analysis of toxicokinetics: a report of JPMA investigation of case studies. J Toxicol Sci 1996, 21:497-504.
15. Igarashi Y. Report from the Japanese Pharmaceutical Manufacturers Association 1994 Seiyakukyo data. Translation of: Report from the Japanese Pharmaceutical Manufacturers Association 1994 Seiyakukyo data
16. Knight A. Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility. Altern Lab Anim 2007, 35:641-659.
17. Knight A, Bailey J, Balcombe J. Animal carcinogenicity studies: 1. Poor human predictivity. Altern Lab Anim 2006, 34:19-27.
18. Koppanyi T, Avery MA. Species differences and the clinical trial of new drugs: a review. Clin Pharmacol Ther 1966, 7:250-270.
19. Lindl T, Voelkel M, Kolar R. [Animal experiments in biomedical research. An evaluation of the clinical relevance of approved animal experimental projects]. ALTEX 2005, 22:143-151.
20. Lindl T, Völkel M, Kolar R. Animal experiments in biomedical research. An evaluation of the clinical relevance of approved animal experimental projects: No evident implementation in human medicine within more than 10 years. ALTEX 2006, 23:111.
21. Litchfield JT. Symposium on clinical drug evaluation and human pharmacology. XVI. Evaluation of the safety of new drugs by means of tests in animals. Clin Pharmacol Ther 1962, 3:665-672.
22. Lumley C. Clinical toxicity: could it have been predicted? Premarketing experience. Animal Toxicity Studies: Their Relevance for Man 1990, 49-56. Quay, Lumley C, Walker S.
23. Perel P, Roberts I, Sena E, Wheble P, Briscoe C, Sandercock P, Macleod M, Mignini LE, Jayaram P, Khan KS. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 2007, 334:197. 10.1136/bmj.39048.407928.BE, 1781970, 17175568.
24. Salsburg D. The lifetime feeding study in mice and rats--an examination of its validity as a bioassay for human carcinogens. Fundam Appl Toxicol 1983, 3:63-67. 10.1016/S0272-0590(83)80174-2, 6884625.
25. Shanks N, Pyles RA. Evolution and medicine: the long reach of "Dr. Darwin". Philos Ethics Humanit Med 2007, 2:4. 10.1186/1747-5341-2-4, 1852567, 17407602.
26. Spriet-Pourra C, Auriche M, . (Eds) SCRIP Reports 1994, PJB, (Eds).
27. Wall RJ, Shani M. Are animal models as good as we think?. Theriogenology 2008, 69:2-9. 10.1016/j.theriogenology.2007.09.030, 17988725.
28. Derbyshire SWG. Time to Abandon the Three Rs. The Scientist 2006, 20:23.
29. Scientific Achievements Less Prominent Than a Decade Ago. Public praises science; scientists fault public, media. , http://people-press.org/report/528/
30. Aldhous P, Coghlan A, Copley J. Let the people speak. New Scientist 1999,
31. Giles J. Animal experiments under fire for poor design. Nature 2006, 444:981. 10.1038/444981a, 17183281.
32. ILAR Science, Medicine, and Animals 2004, Washington, DC: National Academies Press, (32a, P1. 32b, P20.), ILAR.
33. Frey RG. Vivisection, morals and medicine. J Med Ethics 1983, 9:94-97. 10.1136/jme.9.2.94, 1059351, 6876105.
34. Editorial A slippery slope. Nature 2009, 462:699. Editorial.
35. House of Commons Select Committee on Science and Technology Book Blue Skies Research Tenth Report 2007, London: House of Commons. Session 2006-2007, House of Commons Select Committee on Science and Technology.
36. Bosch X. New European funding agency backs "blue-skies" research. JAMA 2007, 297:1644. 10.1001/jama.297.15.1644, 17440137.
37. Vance DE. Phosphatidylethanolamine N-methyltransferase: unexpected findings from curiosity-driven research. Eur J Med Res 1996, 1:182-188.
38. National Environment Research Council Blue Skies Review Final Report 2007, London: NERC, National Environment Research Council.
39. Organisation for Economic Cooperation and Development The Measurement of Scientific and Technical activities: Proposed Standard Practice for Surveys of Research and Development. Paris 1963, Organisation for Economic Cooperation and Development.
40. Bacon F. The Great Instauration and the Novum Organum 1620 2010, Whitefish: Kessinger Publishing, LLC.
41. Bernard C. An Introduction to the Study of Experimental Medicine 1973, P156. New York: Dover.
42. Lord R. The Life of Sir J.J. Thomson 1942, P198. Cambridge: Cambridge University Press.
43. Braben D. Pioneering Research: A Risk Worth Taking 2004, Hoboken: John Wiley and Sons.
44. Kornberg A. Science in the stationary phase. Science 1995, 269:1799. 10.1126/science.7569906, 7569906.
45. General Accounting Office GAO-01-286R Drugs Withdrawn From Market 2001, Washington, DC: US General Accounting Office, General Accounting Office.
46. Holden C. Race and medicine. Science 2003, 302:594-596. 10.1126/science.302.5645.594, 14576420.
47. Weinshilboum R. Inheritance and drug response. N Engl J Med 2003, 348:529-537. 10.1056/NEJMra020021, 12571261.
48. Kaiser J. Gender in the pharmacy: does it matter?. Science 2005, 308:1572. 10.1126/science.308.5728.1572, 15947169.
49. Penny MA, McHale D. Pharmacogenomics and the drug discovery pipeline: when should it be implemented?. Am J Pharmacogenomics 2005, 5:53-62. 10.2165/00129785-200505010-00005, 15727489.
50. Simon V. Wanted: women in clinical trials. Science 2005, 308:1517. 10.1126/science.1115616, 15947140.
51. Mann DL. Targeted cancer therapeutics: the heartbreak of success. Nat Med 2006, 12:881-882. 10.1038/nm0806-881, 16892027.
52. Risch N. Dissecting racial and ethnic differences. N Engl J Med 2006, 354:408-411. 10.1056/NEJMe058265, 16436773.
53. Couzin J. Cancer research. Probing the roots of race and cancer. Science 2007, 315:592-594. 10.1126/science.315.5812.592, 17272699.
54. Couzin J. Human genetics. In Asians and whites, gene expression varies by race. Science 2007, 315:173-174. 10.1126/science.315.5809.173a, 17218500.
55. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, Cheung VG. Common genetic variants account for differences in gene expression among ethnic groups. Nat Genet 2007, 39:226-231. 10.1038/ng1955, 17206142.
56. Willyard C. Blue's clues. Nat Med 2007, 13:1272-1273. 10.1038/nm1107-1272, 17987010.
57. Weiss ST, McLeod HL, Flockhart DA, Dolan ME, Benowitz NL, Johnson JA, Ratain MJ, Giacomini KM. Creating and evaluating genetic tests predictive of drug response. Nat Rev Drug Discov 2008, 7:568-574. 10.1038/nrd2520, 2682785, 18587383.
58. Bhatt DL. Tailoring Antiplatelet Therapy Based on Pharmacogenomics: How Well Do the Data Fit?. JAMA 2009, 302:896-897. 10.1001/jama.2009.1249, 19706866.
59. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.
60. Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, et al. Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy. JAMA 2009, 302:849-857. 10.1001/jama.2009.1232, 19706858.
61. Willyard C. HIV gender clues emerge. Nat Med 2009, 15:830. 10.1038/nm0809-830b, 19661976.
62. Dombrowski D. Babies and Beasts: The Argument from Marginal Cases 1997, Springfield. University of Illinois Press.
63. Dombrowski DA. Is the argument from marginal cases obtuse?. J Appl Philos 2006, 23:223-232. 10.1111/j.1468-5930.2006.00334.x, 17036431.
64. Cohen C, Regan T. The Animal Rights Debate 2001, Lanham: Rowman & Littlefield Publishers, Inc.
65. Rachels J. Created From Animals 1991, Oxford: Oxford University Press.
66. Regan T, Singer P. Animal Rights and Human Obligations 1989, Upper Saddle River: Prentice Hall.
67. Hockfield S. The next innovation revolution. Science 2009, 323:1147. 10.1126/science.1170834, 19251595.
68. Bush V. Science The Endless Frontier: A Report to the President by Vannevar Bush, Director of the Office of Scientific Research and Development 1945, Washington, DC; Office of Scientific researc and Development.
69. Sherwin CW, Isenson RS. Project hindsight. A Defense Department study of the utility of research. Science 1967, 156:1571-1577. 10.1126/science.156.3782.1571, 6025113.
70. Johnson LB. June 15 meeting with US medical and hospital leaders. Quoted in CA Cancer J Clin 1966, 16:256-257.
71. Comroe JH, Dripps RD. Scientific basis for the support of biomedical science. Science 1976, 192:105-111. 10.1126/science.769161, 769161.
72. Grant J, Green L, Mason B. From Bedside to Bench: Comroe and Dripps Revisited 2003, Uxbridge: Health Economics Research Group, (72b, P40.).
73. Freeman M, St Johnston D. Wherefore DMM?. Disease Models & Mechanisms 2008, 1:6-7.
74. LaFollette H, Shanks N. Brute Science: Dilemmas of animal experimentation 1996, New York: Routledge.
75. Comroe JH, Dripps RD. Ben Franklin and Open Heart Surgery. Cardiovasc Dis 1975, 2:361-375. 345728, 15216009.
76. Comroe JH. Answers to a congressman's questions. Circ Res 1969, 25:501-503.
77. Comroe JH, Dripps RD. Ben Franklin and open heart surgery. Circ Res 1974, 35:661-669.
78. Comroe JH. Retrospectroscope: Insights into Medical Discovery 1977, Van Gehr Press.
79. Silverman WA. The unresolved oxygen-level issue: hijacked by anti-trialists. J Perinatol 2004, 24:109-111. 10.1038/sj.jp.7211029, 14872209.
80. Smith R. Comroe and Dripps revisited. Br Med J (Clin Res Ed) 1987, 295:1404-1407. 10.1136/bmj.295.6610.1404, 1248552, 3690250.
81. Farrar S. Key basic research study proves fatally ambiguous. The Times Higher Education 2003, , http://www.timeshighereducation.co.uk/story.asp?storyCode=181279§ioncode=26
82. Grant J, Green L, Mason B. Basic research and health: a reassessment of the scientific basis for the support of biomedical science. Research Evaluation 2003, 12:217-224.
83. Contopoulos-Ioannidis DG, Ntzani E, Ioannidis JP. Translation of highly promising basic science research into clinical applications. Am J Med 2003, 114:477-484. 10.1016/S0002-9343(03)00013-5, 12731504.
84. Lost in clinical translation. Nat Med 2004, 10:879. 10.1038/nm0904-879, 15340394.
85. Crowley WF. Translation of basic research into useful treatments: how often does it occur?. Am J Med 2003, 114:503-505. 10.1016/S0002-9343(03)00119-0, 12727585.
86. Hamilton DP. Publishing by--and for?--the numbers. Science 1990, 250:1331-1332. 10.1126/science.2255902, 2255902.
87. Steinman R, Szalavitz M. Patients Have Been Too Patient With Basic Research. Cerebrum 2002, 4.
88. Ioannidis JP. Materializing research promises: opportunities, priorities and conflicts in translational medicine. J Transl Med 2004, 2:5. 10.1186/1479-5876-2-5, 343300, 14754464.
89. Grant J, Cottrell R, Cluzeau F, Fawcett G. Evaluating "payback" on biomedical research from papers cited in clinical guidelines: applied bibliometric study. BMJ 2000, 320:1107-1111. 10.1136/bmj.320.7242.1107, 27352, 10775218.
90. Chalmers I. Evaluating "payback" on biomedical research. Biomedical funding decisions should be audited. BMJ 2000, 321:566. 10.1136/bmj.321.7260.566, 1118449, 10968826.
91. Buxton M, Hanney S. How can payback from health services research be assessed?. J Health Serv Res Policy 1996, 1:35-43.
92. Silverman WA. Snobbery and gamesmanship in medical research. Paediatr Perinat Epidemiol 2005, 19:2-3. 10.1111/j.1365-3016.2004.00547.x, 15670101.
93. Rothwell PM. Funding for practice-oriented clinical research. Lancet 2006, 368:262-266. 10.1016/S0140-6736(06)69010-7, 16860680.
94. Farewell Address. , http://en.wikisource.org/wiki/Military-Industrial_Complex_Speech
95. News F. Translational research: getting the message across. Nature 2008, 453:839. 10.1038/453839a, 18548042.
96. Butler D. Translational research: crossing the valley of death. Nature 2008, 453:840-842. 10.1038/453840a, 18548043.
97. Begley S. Financial Obstacles Help Keep Doctors From Patient Research. Wall Street Journal 2003,
98. Begley S. Physician-Researchers Needed To Get Cures Out of Rat's Cage. 2003, Wall Street Journal.
99. Mission Statement. , http://www.nida.nih.gov/mediaguide/othergovernment.html
100. UK Clinical Research Collaboration UK Health Research Analysis. London 2006, UK Clinical Research Collaboration.
101. Nathan DG, Schechter AN. NIH support for basic and clinical research: biomedical researcher angst in 2006. JAMA 2006, 295:2656-2658. 10.1001/jama.295.22.2656, 16772630.
102. Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, et al. Central Challenges Facing the National Clinical Research Enterprise. JAMA 2003, 289:1278-1287. 10.1001/jama.289.10.1278, 12633190.
103. Hampton T. Targeted cancer therapies lagging: better trial design could boost success rate. JAMA 2006, 296:1951-1952. 10.1001/jama.296.16.1951, 17062851.
104. Rosenberg RN. Translating biomedical research to the bedside: a national crisis and a call to action. JAMA 2003, 289:1305-1306. 10.1001/jama.289.10.1305, 12633194.
105. Chalmers I. Biomedical research: Are we getting value for money?. Significance 2006, 3:172-175.
106. Bell J. Resuscitating clinical research in the United Kingdom. BMJ 2003, 327:1041-1043. 10.1136/bmj.327.7422.1041, 261667, 14593043.
107. Ioannidis JP. Evolution and translation of research findings: from bench to where?. PLoS Clin Trials 2006, 1:e36. 10.1371/journal.pctr.0010036, 1851723, 17111044.
108. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol 2006, 59:467-477. 10.1002/ana.20741, 16453316.
109. Sigma_Xi Sigma Xi Statements of the Use of Animals in Research. American Scientist 1992, 80:73-76. Sigma_Xi.
110. Ledford H. Translational research: the full cycle. Nature 2008, 453:843-845. 10.1038/453843a, 18548044.
111. Committee on Models for Biomedical Research. Board on Basic Biology Commission on Life Science. National Research Council. Models for Biomedical Research: A New Perspective 1985, Washington, DC: National Academy Press, Committee on Models for Biomedical Research. Board on Basic Biology.
112. Panksepp J. Affective Neuroscience: The Foundations of Human and Animal Emotions (Series in Affective Science) 1998, Oxford: Oxford University Press.
113. Panksepp J. At the interface of the affective, behavioral, and cognitive neurosciences: decoding the emotional feelings of the brain. Brain Cogn 2003, 52:4-14. 10.1016/S0278-2626(03)00003-4, 12812799.
114. Panksepp J. Toward a science of ultimate concern. Conscious Cogn 2005, 14:22-29. 10.1016/j.concog.2004.10.002, 15766889.
115. Panksepp J. Affective consciousness: Core emotional feelings in animals and humans. Conscious Cogn 2005, 14:30-80. 10.1016/j.concog.2004.10.004, 15766890.
116. Panksepp J, Burgdorf J, Beinfeld MC, Kroes RA, Moskal JR. Regional brain cholecystokinin changes as a function of friendly and aggressive social interactions in rats. Brain Res 2004, 1025:75-84. 10.1016/j.brainres.2004.07.076, 15464747.
117. Panksepp J, Nocjar C, Burgdorf J, Panksepp JB, Huber R. The role of emotional systems in addiction. A neuroethological perspective. 50th Nebraska Symposium on Motivation Motivational factors in the etiology of drug abuse. Lincoln 2004, 85-126. Bevins RA.
118. Panksepp JB, Huber R. Ethological analyses of crayfish behavior: a new invertebrate system for measuring the rewarding properties of psychostimulants. Behav Brain Res 2004, 153:171-180. 10.1016/j.bbr.2003.11.014, 15219718.
119. Baldwin A, Bekoff M. Too Stressed to Work. New Scientist 2007, 24.
120. Bekoff M. The Animal Manifesto: Six Reasons for Expanding Our Compassion Footprint 2010, Novato: New World Library.
121. Bekoff M. Aquatic animals, cognitive ethology, and ethics: questions about sentience and other troubling issues that lurk in turbid water. Dis Aquat Organ 2007, 75:87-98. 10.3354/dao075087, 17578248.
122. Bekoff M. Are You Feeling What I'm Feeling?. New Scientist 2007, 42-47.
123. Broom DM. Cognitive ability and sentience: which aquatic animals should be protected?. Dis Aquat Organ 2007, 75:99-108. 10.3354/dao075099, 17578249.
124. Mukerjee M. Book Review of Speaking for the Animals Scientific American. 2004, 96-97.
125. APHIS Rats/Mice/and Birds Database: Researchers, Breeders, Transporters, and Exhibitors. A Database Prepared by the Federal Research Division, Library of Congress under an Interagency Agreement with the United States Department of Agriculture's Animal Plant Health Inspection Service. 2000, Washington, DC: APHIS, APHIS.
126. Horrobin DF. Modern biomedical research: an internally self-consistent universe with little contact with medical reality?. Nat Rev Drug Discov 2003, 2:151-154. 10.1038/nrd1012, 12563306.
127. YewCon. , http://www.yewconservation.org/YewCon/YewCon_Advocacy.html
128. Pennisi E. Beyond yew: chemists boost taxol yield - cancer treatment from yew tree. Science News 1992,
129. Hartzell H, Rust J. The Yew Tree: A Thousand Whispers: Biography of a Species 1990, Cottage Grove:Hulogosi Communications Inc.
130. Blosser SA, Zimmerman HE, Stauffer JL. Do autopsies of critically ill patients reveal important findings that were clinically undetected?. Crit Care Med 1998, 26:1332-1336. 10.1097/00003246-199808000-00015, 9710090.
131. Perkins GD, McAuley DF, Davies S, Gao F. Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Crit Care 2003, 7:R129-132. 10.1186/cc2359, 374369, 14624686.
132. Chain E. Social Responsibility and the Scientist in Modern Western Society. Robert Waley Cohen memorial lecture 1970, P24. London: The Council of Christians and Jews.
133. Midgley M. Wisdom Information and Wonder: What is Knowledge For? 1991, P58. London: Routledge.